SLS
USDSELLAS Life Sciences Group Inc. Common Stock
$1.680-0.070 (-4.000%)
Real-time Price
Healthcare
Biotechnology
United States
Price Chart
Loading Chart...
Key Metrics
Market Metrics
Open
$1.750
High
$1.770
Low
$1.670
Volume
2.79M
Company Fundamentals
Market Cap
247.7M
Industry
Biotechnology
Country
United States
Trading Stats
Avg Volume
3.07M
Exchange
NCM
Currency
USD
52-Week Range
Low $0.77Current $1.680High $2.48
Related News
GlobeNewswire
SELLAS Life Sciences Announces Presentation of Phase 2 Data of SLS009 in Combination with Azacitidine and Venetoclax in Relapsed/Refractory AML with MDS-Related Changes (AML-MR) at the 2025 American Society of Hematology (ASH) Annual Meeting
NEW YORK, Nov. 03, 2025 (GLOBE NEWSWIRE) -- SELLAS Life Sciences Group, Inc. (NASDAQ:SLS) ("SELLAS'' or the "Company"), a late-stage clinical biopharmaceutical company focused on the development of novel therapies for
View more
Related Stocks
AILEW
iLearningEngines Inc. Warrant
NASDAQ
Computer Softwa...
PPL
PPL Corporation
NASDAQ
Electric Utilit...
SOHON
Sotherly Hotels Inc. 8.25% Series D Cumulative Redeemable Perpetual Preferred Stock
NASDAQ
Real Estate Inv...
DLY
DoubleLine Yield Opportunities Fund Common Shares of Beneficial Interest
NASDAQ
Investment Mana...
BLEU
bleuacacia ltd Ordinary Shares
NASDAQ
Blank Checks
Stay Updated
Set price alerts, get AI analysis updates and real-time market news.